UY39957A - Compuestos de imidazopiridazina inhibidores de il-17 - Google Patents

Compuestos de imidazopiridazina inhibidores de il-17

Info

Publication number
UY39957A
UY39957A UY0001039957A UY39957A UY39957A UY 39957 A UY39957 A UY 39957A UY 0001039957 A UY0001039957 A UY 0001039957A UY 39957 A UY39957 A UY 39957A UY 39957 A UY39957 A UY 39957A
Authority
UY
Uruguay
Prior art keywords
inhibitors
compounds
imidazopyridazine compounds
imidazopyridazine
ameliorate
Prior art date
Application number
UY0001039957A
Other languages
English (en)
Spanish (es)
Inventor
D Venable Jennifer
C Behenna Douglas
D Goldberg Steven
Deane Gordon
E Hanna Luke
A Loskot Steven
Stefan Mccarver
E Valdes Alexander
Dongpei Wu
Xiaohua Xue
P Meduna Steven
T Shireman Brock
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of UY39957A publication Critical patent/UY39957A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UY0001039957A 2021-09-27 2022-09-26 Compuestos de imidazopiridazina inhibidores de il-17 UY39957A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163248563P 2021-09-27 2021-09-27
US202163273407P 2021-10-29 2021-10-29
US202263371910P 2022-08-19 2022-08-19

Publications (1)

Publication Number Publication Date
UY39957A true UY39957A (es) 2023-04-14

Family

ID=83693127

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039957A UY39957A (es) 2021-09-27 2022-09-26 Compuestos de imidazopiridazina inhibidores de il-17

Country Status (10)

Country Link
US (2) US12215111B2 (https=)
EP (1) EP4408529A1 (https=)
JP (1) JP2024536863A (https=)
KR (1) KR20240082371A (https=)
AU (1) AU2022348938A1 (https=)
CA (1) CA3233625A1 (https=)
MX (1) MX2024003770A (https=)
TW (1) TW202329933A (https=)
UY (1) UY39957A (https=)
WO (1) WO2023049886A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240082371A (ko) 2021-09-27 2024-06-10 얀센 파마슈티카 엔브이 이미다조피리다진 il-17 억제제 화합물
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
WO2024138286A1 (en) * 2022-12-26 2024-07-04 Usynova Pharmaceuticals, Ltd. Il-17a modulators
WO2024163365A1 (en) * 2023-01-30 2024-08-08 Dice Alpha, Inc. Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof
CN121311483A (zh) * 2023-03-28 2026-01-09 詹森药业有限公司 含内酰胺的咪唑并哒嗪il-17抑制剂化合物
WO2025202922A1 (en) * 2024-03-27 2025-10-02 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI752400B (zh) * 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
GB201909190D0 (en) * 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
KR20230019507A (ko) 2020-04-30 2023-02-08 얀센 파마슈티카 엔.브이. Il-17의 조절제로서의 이미다조피리다진
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
KR20240082371A (ko) 2021-09-27 2024-06-10 얀센 파마슈티카 엔브이 이미다조피리다진 il-17 억제제 화합물
CN116143777A (zh) 2021-11-04 2023-05-23 四川海思科制药有限公司 一种可抑制il-17a的杂环化合物及其用途
TW202413363A (zh) 2021-11-04 2024-04-01 大陸商西藏海思科製藥有限公司 一種可抑制il-17a之雜環化合物及其用途

Also Published As

Publication number Publication date
US12215111B2 (en) 2025-02-04
MX2024003770A (es) 2024-06-19
CA3233625A1 (en) 2023-03-30
US20230147458A1 (en) 2023-05-11
EP4408529A1 (en) 2024-08-07
WO2023049886A1 (en) 2023-03-30
AU2022348938A1 (en) 2024-05-16
TW202329933A (zh) 2023-08-01
US20250206744A1 (en) 2025-06-26
JP2024536863A (ja) 2024-10-08
KR20240082371A (ko) 2024-06-10

Similar Documents

Publication Publication Date Title
ECSP22091485A (es) Imidazolpiridazinas como moduladores de il-17
UY39958A (es) Compuestos de imidazopiridazina inhibidores de il-17
UY39957A (es) Compuestos de imidazopiridazina inhibidores de il-17
CO2019007810A2 (es) Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer
CO2018006137A2 (es) Compuestos de diamina-arilsulfonamida sustituidos con hidroxialquilamina e hidroxicicloalquilamina con actividad selectiva en canales de sodio activados por voltaje
NI201500031A (es) Métodos para tratar la enfermedad de alzheimer y composiciones farmacéuticas de los mismos.
NI201500140A (es) Compuestos y composiciones terapéuticos
CL2019002900A1 (es) Análogos de benzoazepina como agentes inhibidores de la tirosina cinasa de bruton.
CR20170071A (es) Compuestos terapeuticos y composiciones
CR11510A (es) Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer
MX2022013650A (es) Imidazopirimidinas como moduladores de il-17.
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
MX2024009943A (es) Inhibidores de arn helicasa dhx9 y usos de los mismos
MX389545B (es) Compuestos terapeuticos y composiciones para el tratamiento de trastornos sociales y trastornos de uso de sustancias.
MX2021006951A (es) Formas cristalinas y formas de sal de un inhibidor de cinasa.
ECSP19019613A (es) Compuestos de aza–indazol para usar en lesiones de tendones y/o ligamentos
MX2019003317A (es) Metodo para tratar cancer usando una combinacion de agentes que dañan adn e inhibidores de proteina cinasa dependiente de adn (adn-pk).
AR084216A1 (es) Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k e inhibidor de mek, kit
ES2582660T3 (es) Sidnoniminas - inhibidores específicos de la recaptación de la dopamina y su uso en el tratamiento de los trastornos relacionados con la dopamina
MX2021006915A (es) Inhibidores de cxcr7 para el tratamiento de cancer.
BR112022024700A2 (pt) Inibidores de atr e usos dos mesmos
MX2018000539A (es) Inhibidores de il-8 para utilizarse en el tratamiento de ciertos trastornos urologicos.
AR127149A1 (es) Compuestos de imidazopiridazina inhibidores de il-17
CL2022002989A1 (es) Imidazopiridazinas como moduladores de il-17.
AR105400A1 (es) Inhibidores de jak1

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20230929